vaccine News
Most Popular vaccine Story
Glaxo snags Alzheimer's vax rights in €452.5M deal
GlaxoSmithKline has put down €22.5 million and promised up to €430 million more to license the rights to two early-stage Alzheimer's disease vaccines from Austria's AFFiRiS. Glaxo picks up... Read more...
Latest Headlines
- November 20, 2008
- November 20, 2008
- November 20, 2008
- November 20, 2008
- November 13, 2008
- November 12, 2008
- November 10, 2008
- November 6, 2008
- November 5, 2008
- October 30, 2008
- October 30, 2008
- October 28, 2008
- October 27, 2008
- October 23, 2008
- October 23, 2008
- October 23, 2008
- October 23, 2008
- October 23, 2008
- October 21, 2008
- October 16, 2008
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
